Go Pro
NYSE:TFX

Teleflex (TFX) Stock Price, News & Analysis

Teleflex logo
$139.81 +2.10 (+1.52%)
As of 08/28/2026 03:58 PM Eastern

About Teleflex Stock (NYSE:TFX)

Advanced

Key Stats

Today's Range
$137.35
$140.57
50-Day Range
$121.85
$140.07
52-Week Range
$100.18
$145.00
Volume
429,347 shs
Average Volume
652,772 shs
Market Capitalization
$5.92 billion
P/E Ratio
N/A
Dividend Yield
0.97%
Price Target
$152.90
Consensus Rating
Hold

Company Overview

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions. Its portfolio features vascular access catheters and needle products, ureteral and stone management systems, airway management and respiratory care devices, laparoscopic instruments, hemostasis products and surgical stapling technologies. Teleflex also partners with other device manufacturers to supply custom components and subassemblies.

Founded in 1943, Teleflex originally operated in the industrial cable market before shifting its focus to the healthcare sector through strategic acquisitions and internal development. A landmark transaction in 2010 was the acquisition of Arrow International, which significantly expanded its presence in vascular access and interventional care. Today, Teleflex maintains manufacturing and research facilities across North America, Europe, Asia and Latin America and serves patients in more than 150 countries.

The company is led by President and Chief Executive Officer Benson Smith, supported by an executive team responsible for global operations, research and development, and regulatory affairs. Teleflex continues to invest in innovation and partnerships to address emerging clinical needs and enhance procedural efficiency for physicians and care teams worldwide.

AI Generated. May Contain Errors.

Teleflex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

TFX MarketRank™: 

Teleflex scored higher than 70% of companies evaluated by MarketBeat, and ranked 249th out of 919 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Teleflex has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on 1 strong buy rating, 4 buy ratings, 6 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for Teleflex is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Teleflex has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Teleflex's stock forecast and price target.
  • Earnings Growth

    Earnings for Teleflex are expected to grow by 46.56% in the coming year, from $7.26 to $10.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Teleflex is -6.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Teleflex is -6.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Teleflex has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Teleflex has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Teleflex's valuation and earnings.
  • Percentage of Shares Shorted

    11.49% of the float of Teleflex has been sold short.
  • Short Interest Ratio / Days to Cover

    Teleflex has a short interest ratio ("days to cover") of 6.36.
  • Change versus previous month

    Short interest in Teleflex has recently increased by 59.70%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Teleflex has a dividend yield of 0.97%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Teleflex does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Teleflex will have a dividend payout ratio of 12.78% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

  • Read more about Teleflex's dividend.
  • News Sentiment

    Teleflex has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Teleflex this week, compared to 6 articles on an average week.
  • Search Interest

    4 people have searched for TFX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Teleflex to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Teleflex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.70% of the stock of Teleflex is held by insiders.

  • Percentage Held by Institutions

    95.62% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Teleflex's insider trading history.
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TFX Stock News Headlines

Teleflex Earnings Call: EPS Up, Integration Weighs
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
Teleflex (TFX) Q2 2026 Earnings Call Transcript
Teleflex Inc.
See More Headlines

TFX Stock Analysis - Frequently Asked Questions

Teleflex's stock was trading at $122.07 on January 1st, 2026. Since then, TFX stock has increased by 14.5% and is now trading at $139.81.

Teleflex Incorporated (NYSE:TFX) posted its quarterly earnings data on Thursday, August, 6th. The medical technology company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.48. The firm's revenue was up 28.9% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Teleflex include California State Teachers Retirement System (15.22%), BlackRock Inc. (12.27%), Jupiter Topco LLC (10.25%) and Pzena Investment Management LLC (1.36%). Insiders that own company stock include Liam Kelly, Thomas E Powell, Cameron P Hicks, Stuart A Randle, Andrew A Krakauer and Jaewon Ryu.
View institutional ownership trends
.

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Teleflex investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Home Depot (HD), Advanced Micro Devices (AMD) and Netflix (NFLX).

Company Calendar

Ex-Dividend for 6/30 Dividend
5/22/2026
Record date for 6/30 Dividend
5/25/2026
Dividend Payable
6/30/2026
Last Earnings
8/06/2026
Record date for 9/30 Dividend
8/14/2026
Ex-Dividend for 9/30 Dividend
8/14/2026
Today
8/29/2026
Dividend Payable
9/30/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:TFX
CIK
96943
Employees
15,500
Year Founded
1943

Price Target and Rating

High Price Target
$170.00
Low Price Target
$135.00
Potential Upside/Downside
+9.4%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($23.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
19.26
P/E Growth
0.93
Net Income
-$905.64 million
Net Margins
-39.67%
Pretax Margin
-2.44%
Return on Equity
11.93%
Return on Assets
5.44%

Debt

Debt-to-Equity Ratio
0.94
Current Ratio
2.60
Quick Ratio
2.12

Sales & Book Value

Annual Sales
$1.99 billion
Price / Sales
2.97
Cash Flow
$11.20 per share
Price / Cash Flow
12.48
Book Value
$68.55 per share
Price / Book
2.04

Miscellaneous

Outstanding Shares
42,370,000
Free Float
42,075,000
Market Cap
$5.92 billion
Optionable
Optionable
Beta
0.81

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:TFX) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners